CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 8-K Event Executive or director change
- 4 Open-market sale Director sold 19,500,000 shares at an average $0.01 ($229,172)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Delisting notice
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Agreement ended · Acquisition or sale completed
- 4 Open-market sale 10% owner sold 64,052,538 shares at an average $0.11 ($6,890,236)
- 8-K Event Material agreement · Exit or restructuring costs · Executive or director change · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 2 of 41 · 808 filings